St. Jude Medical, Inc. (STJ)
Develops, manufactures and distributes cardiovascular medical devices for the cardiac rhythm management, cardiac surgery, cardiology, and atrial fibrillation therapy areas and implantable neuromodulation devices for the management of chronic pain.
Recs
1jeshua
(31.54)
Submitted: 10/11/2006 2:44:30 AM :
Start Price:
$38.40
STJ Score:
+8.13
After the Acquisition, and everything is finally back to normal.
Recs
4mybluedog
(59.49)
Submitted: 1/16/2008 10:56:10 AM :
Start Price:
$41.50
STJ Score:
+3.66
this dog has an angel on his shoulders.
Recs
Recs
akbm7195
(76.11)
Submitted: 1/12/2008 5:35:26 PM :
Start Price:
$43.14
STJ Score:
+3.05
defenisve and growing
Recs
bdz
(85.49)
Submitted: 4/21/2007 9:37:26 AM :
Start Price:
$43.30
STJ Score:
-5.60
Soft spot for St Jude
Recs
bebop111
(49.84)
Submitted: 9/27/2006 6:22:21 PM :
Start Price:
$34.62
STJ Score:
+17.90
Only 10% off its 52-week bottom, poised to break through resistance point. A growth stock, with a bit of value now, the PEG is a respectable 1.55. With great operating margin, and return on equity, and especially, new products expected down the line, this should get into the mid 40's in next 6 months.
Recs
BuffLamp
(34.99)
Submitted: 12/5/2007 12:30:08 AM :
Start Price:
$39.57
STJ Score:
+14.09
Solid Finances. Lots of Margin of Safety. People are getting older but not healthier. Solid long term play
Recs
buzzsaw52
(< 20)
Submitted: 11/16/2006 5:35:25 PM :
Start Price:
$35.81
STJ Score:
+18.25
New, physician friendloy software will give it an edge
Recs
buzzstocks
(36.18)
Submitted: 4/17/2009 5:33:42 PM :
Start Price:
$35.77
STJ Score:
-28.71
Life-saving devices that target heart disease. Higher than expected Q3 sales, and well insulated from macro turmoil.
Recs
coryjobe
(88.51)
Submitted: 5/16/2009 11:02:52 PM :
Start Price:
$37.23
STJ Score:
-26.85
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiac surgery, cardiology, and atrial fibrillation therapy areas and implantable neuromodulation devices. Has four main perating segments
December-quarter sales were up 1.1 billion, 11% from last year, the Cardiac Rhythm Management segment recorded a 7% top-line gain. The Cardiovascular Business also recorded a 7% gain, and the Neuromodulation (which is fun to say, made me feel smart) was up 32%
The CRM is becoming much more crowed as the baby boomers start to get older (I should look into who makes depends) and St. Jude is well positioned to take advantage of this, also the Atrial Fibrillation and Neuromodulation (had to throw it in again) offer significant long-term growth opportunities
Recs
dfcjh
(< 20)
Submitted: 8/16/2008 10:28:32 PM :
Start Price:
$46.30
STJ Score:
-8.66
medical stocks eem to do well in the current marketenviornment. Stocks down medical stocks up. Baby Boomers aren't getting any younger and still want to live forever!
Recs
diversified1
(60.20)
Submitted: 10/29/2007 11:53:52 PM :
Start Price:
$40.60
STJ Score:
+14.57
They are solid!
Recs
doktorv
(82.34)
Submitted: 9/5/2006 10:21:30 PM :
Start Price:
$36.38
STJ Score:
+10.41
Forget ICD sales in the USA. Focus on worldwide growth.
Recs
dwbourn
(31.04)
Submitted: 9/27/2007 10:17:49 PM :
Start Price:
$44.08
STJ Score:
+7.12
STJ is becoming very aggressive in the field and are taking market share from BSX (CRM Arena). They are moving into the number 2 spot behind MDT. If they can keep this momentum going there should be some appreciation.
Recs
dy542340
(< 20)
Submitted: 1/29/2007 12:51:25 PM :
Start Price:
$41.91
STJ Score:
+4.84
ICD sales will return to double digit growth in 2007. SJM will be an acquisition target
Recs
edinberlin
(22.26)
Submitted: 3/15/2007 9:32:14 AM :
Start Price:
$38.44
STJ Score:
+10.69
A truly innovative medical devise company.
Recs
furleather
(84.21)
Submitted: 10/4/2006 7:01:07 PM :
Start Price:
$37.29
STJ Score:
+10.57
equity was oversold, now at an attractive entry point
Recs
gEEkguy
(< 20)
Submitted: 2/2/2007 1:29:40 PM :
Start Price:
$41.87
STJ Score:
+6.22
ICD market is under penetrated.
Recs
gostj
(65.93)
Submitted: 12/7/2006 5:19:32 PM :
Start Price:
$38.53
STJ Score:
+11.70
ICD market to rebound
Recs
hd4fun
(61.38)
Submitted: 10/4/2006 11:44:08 AM :
Start Price:
$37.09
STJ Score:
+10.88
continuing to take market share
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 49 1 2 3 Next »